Search the Newsreel

XinXiang Era Group Company Limited Revenue Breakdown – HKEX:8519

Quanex Building Products Corp (NX) Financial Health: Profitability & Balance Sheet Analysis

Quanex Building Products Corp (NX) has a weak financial status with an average operating efficiency, according to TradingKey, which ranks its financial score at 6.44 out of 54 in its industry. The company recently reported a quarterly revenue of $462.37 million, marking a 2.19% …

RGNX|Regenxbio Inc|Price:10.180|Chg%:+0.060

The article provides a comprehensive stock analysis of Regenxbio Inc (RGNX) from TradingKey, highlighting its relatively weak fundamentals but significant growth potential. The stock is considered fairly valued, with high institutional ownership and multiple "Buy" ratings from analysts. The company, a clinical-stage biotechnology firm, …

Quanex Building Products Corp (NX) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Quanex Building Products Corp (NX), detailing its current price momentum score, support and resistance levels, and indicator readings. It also offers insights into various technical indicators like MACD, RSI, and moving averages, along with FAQs about technical …

Talonx advances Viking gold and Kihabe base metals as management swaps cash for shares

Crane NXT Co (CXT) Cash Flow

This article provides a detailed cash flow statement for Crane NXT Co (CXT), including quarterly and annual data for operating, investing, and financing activities. It presents financial figures with year-over-year percentage changes and defines key cash flow terms through a frequently asked questions section. …

Quanex Building Products Number of Employees 2026 | Employee Count & Headcount Data

Quanex Building Products (NX) had 7,090 employees globally as of March 2026, marking a 0.1% decline from 2023. The company is actively hiring with 313 job postings in 2026, a 39.4% increase from 2025. Its workforce is primarily in North America, with an average …

CNX Resources Corp 2026: Revenue $618.48M, EPS $1.32— 10-Q Summary

CNX Resources Corp (CNX) reported its 2026 quarterly results, showing a significant decrease in revenue to $618.48M and diluted EPS to $1.32, down from the previous year. Net income also fell by 53.1%. The company attributed the revenue decline partly to lower gas volumes, …

CNX Resources (NYSE:CNX) Issues Quarterly Earnings Results, Beats Expectations By $0.72 EPS

CNX Resources (NYSE:CNX) reported strong quarterly earnings, beating analyst expectations by $0.72 per share with an EPS of $1.32, despite revenue of $435 million falling short of estimates. The company anticipates improved low-carbon revenue prospects due to revised Treasury calculations for 45Z credits, targeting …

Lake Street Maintains Pulmonx(LUNG.US) With Buy Rating, Maintains Target Price $4

Lake Street has reiterated its Buy rating for Pulmonx (LUNG.US) and maintained its price target at $4. This indicates a continued positive outlook from the firm regarding the company's stock performance.

NXPI Q2 Deep Dive: Broad-Based Revenue Growth and Strong Guidance Across All End Markets

NXPI Q2 Deep Dive: Broad-Based Revenue Growth and Strong Guidance Across All End Markets Chip manufacturer NXP Semiconductors (NASDAQ: NXPI) reported revenue ahead of Wall Street's expectations in Q2 CY2026, with sales up 19.5% year on year to $3.50 billion. Guidance for next quarter's …

Pulmonx Stock Rises On Narrowed Q2 Losses, Margin Gains

(RTTNews) - Pulmonx Corporation (LUNG), a medical device company focused on minimally invasive treatments for lung disease, yesterday announced financial results for the second quarter ended June 30, 2026, showing lower revenue compared to the same period last year but improved margins and reduced …

Earnings call transcript: CNX beats Q2 2026 estimates as credit gains lift profit

CNX Resources Corp. reported Q2 2026 earnings that significantly exceeded Wall Street expectations for both profit and revenue, driven by strong operational execution and monetization of low-carbon credits. Despite the strong financial performance, the stock experienced a slight decline in early trading, reflecting investor …

The Charts Reveal Significant Price Movement in Forte Biosciences Stock Ahead of Argenx’s Acquisition Announcement

3d illustration inflation and deflation graph by Deepadesigns via Shutterstock Argenx (ARGX) announced the acquisition of Forte Biosciences (FBRX) at $77 per share on July 27. FBRX saw significant price movement beginning June 29, weeks before the public announcement. Both FBRX and ARGX exhibited …

IperionX shares slump following June quarter update

Shares in IperionX tumbled despite the titanium producer advancing its Virginia commercial operations and Hydrogen-Assisted Metallothermic Reduction (HAMR) systems production. The company reported consistent performance from its HAMR power production and aims for a run-rate production capacity of 200 tonnes per annum of titanium …

Press Release: IperionX -- June 2026 Quarterly Report

IperionX has released its Quarterly Report for June 2026. Further details are available within the accompanying document.

CNX Reports Second Quarter Results

CNX Resources Corporation announced its second-quarter 2026 financial and operational results, which are available on its website. The company also provided details for its Q&A conference call scheduled for July 30, 2026, at 10:00 a.m. ET. CNX, an ultra-low carbon intensive natural gas company …

NXP Semiconductors Number of Employees 2026 | Employee Count & Headcount Data

NXP Semiconductors (NASDAQ: NXPI) had approximately 32,057 employees worldwide as of March 2026, a 5.3% decline since 2023. The company is actively hiring, with 735 job postings in 2026, a 34.6% increase from 2025. The workforce is concentrated in Western Europe, and the average …

Janus Henderson Group PLC Raises Stock Position in NXP Semiconductors N.V. $NXPI

Janus Henderson Group PLC increased its stake in NXP Semiconductors N.V. by 19.6% in the first quarter, now owning 1.22% of the company's shares. NXP Semiconductors recently reported strong Q2 earnings, exceeding analyst expectations with $3.61 EPS and $3.50 billion in revenue, prompting a …

IperionX Limited Sponsored ADR (NASDAQ:IPX) Receives Average Rating of "Moderate Buy" from Brokerages

IperionX Limited Sponsored ADR (NASDAQ:IPX) has received an average "Moderate Buy" rating from six analysts, with an average 12-month price target of $60.33. Recent insider buying by Chairman Todd Hannigan and CEO Anastasios Arima, totaling 663,720 shares worth approximately $2.38 million, indicates confidence in …

IperionX (Nasdaq: IPX) raises $50M to fund titanium and Atlas-Titan growth

IperionX (Nasdaq: IPX) has successfully raised approximately $50 million through an underwritten public offering of American Depositary Shares, significantly boosting its pro-forma cash to about $84 million. This funding, combined with substantial U.S. Government support, will primarily finance the expansion of its titanium manufacturing …

Amundi Decreases Stock Position in NXP Semiconductors N.V. $NXPI

Amundi reduced its stake in NXP Semiconductors N.V. by 12.8% in Q1 2026, selling 281,066 shares but retaining 1.92 million shares valued at $378.4 million. Despite NXP Semiconductors exceeding Q2 earnings and revenue estimates and raising Q3 guidance, its shares fell by 7%. Institutional …

Crane NXT Co. (CXT) Q1 2026 Earnings: EPS Beat Fails to Lift Shares - Book Value Growth

Crane NXT Co. (CXT) Q1 2026 Earnings: EPS Beat Fails to Lift Shares - Earnings Momentum Score

IperionX Limited (IPX) Releases Quarterly Earnings: Revenue and Profit Decline

CNX Resources earnings beat by $0.71, revenue topped estimates

CNX Resources Corporation. (CNX) came out with quarterly earnings of $0.72 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.59 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents …

REGENXBIO (RGNX) Projected to Post Earnings on Thursday

Hedges, refinancing and buybacks shape CNX Resources (NYSE: CNX) quarter

CNX Resources’s (NYSE:CNX) Q2 CY2026: Strong Sales

CNX Resources's (NYSE:CNX) Q2 CY2026: Strong Sales Natural gas producer CNX Resources (NYSE:CNX) reported Q2 CY2026 results beating Wall Street's revenue expectations , with sales up 29.2% year on year to $618.5 million. Its GAAP profit of $1.32 per share was significantly above analysts' …

CNX Resources Corporation. (CNX) Q2 Earnings Beat Estimates

NXP Semiconductors (NXPI) Stock Rebounds As Margins Strengthen And AI Growth Builds

BofA cuts NXP Semiconductors stock price target on growth concerns By Investing.com

BofA Securities has lowered its price target for NXP Semiconductors NV to $300 from $310, while maintaining a Neutral rating, despite raising its earnings estimates for fiscal 2026 and 2027. The firm cited concerns about growth being primarily content-led, lack of restocking signals from …

Pulmonx Affirms FY26 Sales Guidance of $90.000M-$92.000M

Pulmonx (NASDAQ: LUNG) has reiterated its full-year 2026 sales guidance, keeping the range at $90.000 million to $92.000 million. This guidance is consistent with previous statements and aligns closely with the consensus analyst estimate of $90.832 million. The affirmation signals management's confidence in the …

Pulmonx Corp Q2 revenue falls, but beats estimates

Pulmonx Corp's Q2 revenue experienced a decline but still managed to surpass analyst estimates. The article, sourced from Reuters via TradingView News, provides a brief update on the company's financial performance.

IperionX Targets Run-Rate Production Capacity of Around 200 Tonnes Per Year of Titanium Powder by 2026-End

IperionX announced plans to achieve a run-rate production capacity of approximately 200 tonnes per year of titanium powder by the end of 2026. This target is driven by the company's patented titanium technologies and aligns with growing demand in various advanced manufacturing sectors. The …

Pulmonx Corporation (LUNG) Reports Q2 Loss, Beats Revenue Estimates

Pulmonx Corporation (LUNG) reported a Q2 loss of $0.24 per share, surpassing the Zacks Consensus Estimate of a $0.28 loss, and also beat revenue expectations with $22.76 million. Despite underperforming the market year-to-date, the company has consistently topped revenue estimates in the past four …